"The advent of HD ten years ago was the last breakthrough in laparoscopic vision," says Wayne Poll, M.D, FloShield inventor and CEO of MID. Â "FloShield represents the last hurdle in laparoscopic visualization."
The FloShield system, which received FDA
510(k) approval in 2008, is in early distribution within the U.S., and in use at approximately 40 hospitals throughout the country. Â The system was certified ISO 13485 compliant in December of 2010, clearing the path for CE Marking. Â
"We have been contacted by several European and Asian distributors who are interested in FloShield," says Poll
is manufactured in Franklin, OH. Â Poll
says the company has more than tripled employment over the last two years from four full time employees to 14.
About Minimally Invasive Devices, Inc.
Minimally Invasive Devices, Inc. (MID) was founded in 2007, by Wayne Poll, M.D., a laparoscopic surgeon. Â MID's first market offering is the FloShieldâ„¢ system of laparoscopic visualization devices. Â The FloShield franchise will soon add Flo-Xâ„¢, the first biocompatible agent with 510(k) clearance for washing the lens of the laparoscope in situ. Â The company is also developing complimentary technology that manages the entire air space in laparoscopic surgery, which will improve the environment and experience for laparoscopic surgeons. Â